NRIX Nurix Therapeutics, Inc.
Healthcare$17.38-0.69%ClosedMarket Cap: $1.51B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
17
Dispositions
17
Buy/Sell Ratio
1.00
Net Shares
+205,439
Shares Acquired
275,824
Shares Disposed
70,385
Total Bought ($)
$0.00
Total Sold ($)
$8.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri May 15 | Silva Paul M | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | Saltzman Edward C | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | Reinsdorf Judith A | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | Lacey David L. | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | Kapur Anil | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | GREGORY JULIA P | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | DANSEY ROGER D | director | Sell | 31,250 | $15.86 | 31,250 |
| Fri May 15 | Baynes Roy D. | director | Sell | 31,250 | $15.86 | 31,250 |
| Tue May 05 | van Houte Hans | officer: Chief Financial Officer | Sell | 13,473 | $16.58 | 38,174 |
| Tue May 05 | van Houte Hans | officer: Chief Financial Officer | Sell | 582 | $17.18 | 37,592 |
| Mon May 04 | Ring Christine | officer: Chief Legal Officer | Sell | 8,148 | $16.96 | 18,305 |
| Fri May 01 | Ring Christine | officer: Chief Legal Officer | Sell | 5,394 | $16.76 | 26,453 |
| Thu Apr 30 | van Houte Hans | officer: Chief Financial Officer | Sell | 2,388 | $16.65 | 51,647 |
| Thu Apr 30 | van Houte Hans | officer: Chief Financial Officer | Sell | 3,750 | $0.00 | 51,177 |
| Thu Apr 30 | van Houte Hans | officer: Chief Financial Officer | Sell | 2,858 | $0.00 | 54,035 |